Curis, Inc. CRIS
0.83
(0.05)
(5.68%)
as of 25 Sep
- Market cap
- $1.8M
- P/E
- 0.0×
Follow CRIS
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
312.10% | 2,829.10% | (693.95%) | 455.35% | |
| (104.28%) | (24.77%) | (61.34%) | (87.76%) | ||
ROIC |
0.00% | (890.43%) | 0.00% | 0.00% | |
Return on Tangible Assets |
618.86% | 106.80% | (1,251.63%) | 306.34% | |
Average Days of Receivables |
101.60 | 0.00 | — | — | |
Free Cash Flow per Share |
(38.38) | (41.33) | (29.90) | (14.32) | |
Free Cash Flow |
(30.09) | (27.20) | (28.95) | (30.59) | |
Piotroski F-Score |
3.00 | 3.00 | — | — | |
| Other line items | |||||
Cash ROIC |
533.51% | (258.49%) | (104.48%) | (296.62%) | |
Accounts Receivable Turnover |
3.75 | 0.00 | — | — | |
Accounts Payable Turnover |
0.02 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | — | — | — | |
Average Days of Payables |
26,168.15 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | — | — | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
269.50% | 299.21% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
124.61% | 148.75% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
38.65% | 42.55% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.82 | 3.59 | 1.37 | 1.45 | |
Depreciation/Fixed assets |
5.89 | 2.73 | 2.19 | 1.83 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
14.86 | 14.35 | 0.00 | 0.00 | |
Operating CF per Share |
(38.38) | (41.33) | (29.90) | (14.32) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
(313.79%) | (80.29%) | 0.00% | 0.00% |
Columns are period end dates